These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 19469544)
1. Synthesis and evaluation of sphingosine analogues as inhibitors of sphingosine kinases. Wong L; Tan SS; Lam Y; Melendez AJ J Med Chem; 2009 Jun; 52(12):3618-26. PubMed ID: 19469544 [TBL] [Abstract][Full Text] [Related]
2. Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C. Yoshimitsu Y; Oishi S; Miyagaki J; Inuki S; Ohno H; Fujii N Bioorg Med Chem; 2011 Sep; 19(18):5402-8. PubMed ID: 21868240 [TBL] [Abstract][Full Text] [Related]
3. Sphingosine kinase inhibitors: A patent review. Cao M; Ji C; Zhou Y; Huang W; Ni W; Tong X; Wei JF Int J Mol Med; 2018 May; 41(5):2450-2460. PubMed ID: 29484372 [TBL] [Abstract][Full Text] [Related]
4. Introduction of a Polar Functional Group to the Lipid Tail of 4-epi-Jaspine B Affects Sphingosine Kinase Isoform Selectivity. Inuki S; Miyagawa T; Oishi S; Ohno H Chem Pharm Bull (Tokyo); 2018; 66(9):866-872. PubMed ID: 30175743 [TBL] [Abstract][Full Text] [Related]
5. Metastatic triple-negative breast cancer is dependent on SphKs/S1P signaling for growth and survival. Maiti A; Takabe K; Hait NC Cell Signal; 2017 Apr; 32():85-92. PubMed ID: 28108260 [TBL] [Abstract][Full Text] [Related]